Document is current
Any future updates will be listed below
-
Authors
Tobias, Deirdre K.
Hazra, Aditi
Lawler, Patrick R.
Chandler, Paulette D.
Chasman, Daniel I.
Buring, Julie E.
Lee, I-Min
Cheng, Susan
Manson, JoAnn E.
Mora, Samia
-
Funding
Funding for this research was provided by:
National Institutes of Health (K01DK103720)
National Institutes of Health (CA-047988)
National Institutes of Health (HL-043851)
National Institutes of Health (HL-080467)
National Institutes of Health (HL-099355)
National Institutes of Health (UM1 CA182913)
National Institutes of Health (R01HL134811)
National Institutes of Health (R01AG051654)
National Institutes of Health (K24 HL136852)
National Institutes of Health (DK112940)
Molino Family Trust
- License Information
-
More Information
Article History
Received: 15 June 2020
Accepted: 28 August 2020
First Online: 6 October 2020
Competing interests
: S.M. has received personal consulting fees from Quest Diagnostics outside the current work; S.M. and P.C. are listed as co-inventors on a patent for an NMR-measured biomarker (GlycA) with colorectal cancer risk.
